Document is current
Any future updates will be listed below
-
Authors
McGuinness, Myra B. http://orcid.org/0000-0002-5422-040X
Robman, Liubov
Hodgson, Lauren A. B.
Tran, Cammie
Woods, Robyn L.
Owen, Alice J.
McNeil, John J.
Makeyeva, Galina
Abhayaratna, Walter P.
Guymer, Robyn H. http://orcid.org/0000-0002-9441-4356
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1127060, 1051625, 1103013, 1173690, 471460, 1028368, 1173690, 1103013)
U.S. Department of Health & Human Services | National Institutes of Health (UO1AG029824, U19AG062682, R01EY026890)
U.S. Department of Health & Human Services | National Institutes of Health
Victorian Cancer Agency
Monash University
U.S. Department of Health & Human Services | National Institutes of Health
Jack Brockhoff Foundation
State Government of Victoria
- License Information
-
More Information
Article History
Received: 10 March 2023
Revised: 6 September 2023
Accepted: 12 September 2023
First Online: 20 September 2023
Competing interests
: RHG is a consultant for Bayer, Novartis, Roche Genentech, Apellis, and Belite Bio. MBM is a consultant for Belite Bio.
